Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.
Alto Crescimento
A receita da empresa tem crescido de forma consistente nos últimos 3 anos, com média de 19.05% ano a ano.
Alto Crescimento de Lucro
O lucro líquido da empresa lidera o setor, com o lucro anual mais recente totalizando US$ 8.48B.
Subavaliada
O PE mais recente da empresa é 9.50, em uma faixa percentil baixa de 3 anos.
Venda Institucional
As participações institucionais mais recentes são de 148.94M ações, uma redução de 5.51% em relação ao trimestre anterior.
Mantido por Brandes Investment
O Super Investidor Brandes Investment possui 63.32M ações desta empresa.